These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9507210)

  • 1. Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury.
    Lianos EA; Guglielmi K; Sharma M
    Kidney Int; 1998 Mar; 53(3):645-53. PubMed ID: 9507210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis.
    Datta PK; Koukouritaki SB; Hopp KA; Lianos EA
    J Am Soc Nephrol; 1999 Dec; 10(12):2540-50. PubMed ID: 10589693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis.
    Datta PK; Dhupar S; Lianos EA
    Nephrol Dial Transplant; 2006 Jan; 21(1):51-7. PubMed ID: 16204297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritis.
    Westenfeld R; Gawlik A; de Heer E; Kitahara M; Abou-Rebyeh F; Floege J; Ketteler M
    Kidney Int; 2002 Mar; 61(3):834-8. PubMed ID: 11849434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis; effects of selective inhibition in neutrophil-dependent glomerulonephritis.
    Waddington SN; Mosley K; Cattell V
    Clin Exp Immunol; 1999 Nov; 118(2):309-14. PubMed ID: 10540196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between inducible nitric oxide synthase and heme oxygenase-1 in glomerulonephritis.
    Datta PK; Gross EJ; Lianos EA
    Kidney Int; 2002 Mar; 61(3):847-50. PubMed ID: 11849436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
    Lianos EA; Bresnahan BA
    J Lab Clin Med; 1999 Nov; 134(5):478-82. PubMed ID: 10560941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible nitric oxide synthase induction in Thy 1 glomerulonephritis is complement and reactive oxygen species dependent.
    Mosley K; Waddington SN; Ebrahim H; Cook T; Cattell V
    Exp Nephrol; 1999; 7(1):26-34. PubMed ID: 9892811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 1999 Jun; 55(6):2264-73. PubMed ID: 10354274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis.
    Gabbai FB; Boggiano C; Peter T; Khang S; Archer C; Gold DP; Kelly CJ
    J Immunol; 1997 Dec; 159(12):6266-75. PubMed ID: 9550431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in glomerular thromboxane A2 receptor expression and ligand binding following immune injury.
    Bresnahan BA; Dufek S; Wu S; Lianos EA
    Kidney Int; 1999 Jan; 55(1):139-47. PubMed ID: 9893122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
    Wang Y; Tong J; Tang R; Dong H; Xu J
    Nephron Physiol; 2004; 98(3):p80-8. PubMed ID: 15528953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of hydroxyeicosatetraenoic acids and leukotrienes in rat nephrotoxic serum glomerulonephritis. Role of anti-glomerular basement membrane antibody dose, complement, and neutrophiles.
    Lianos EA
    J Clin Invest; 1988 Aug; 82(2):427-35. PubMed ID: 2841352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm.
    Harkin DW; Rubin BB; Romaschin A; Lindsay TF
    J Surg Res; 2004 Aug; 120(2):230-41. PubMed ID: 15234218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
    Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of phospholipase A2 and lipoxygenase in lipopolysaccharide-induced inducible nitric oxide synthase expression in glial cells.
    Won JS; Im YB; Khan M; Singh AK; Singh I
    Glia; 2005 Jul; 51(1):13-21. PubMed ID: 15779087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
    Theuer J; Shagdarsuren E; Muller DN; Kaergel E; Honeck H; Park JK; Fiebeler A; Dechend R; Haller H; Luft FC; Schunck WH
    Kidney Int; 2005 Jan; 67(1):248-58. PubMed ID: 15610248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of glomerular arginine transporters (CAT-1 and CAT-2) in lipopolysaccharide-treated rats.
    Schwartz D; Schwartz IF; Gnessin E; Wollman Y; Chernichovsky T; Blum M; Iaina A
    Am J Physiol Renal Physiol; 2003 Apr; 284(4):F788-95. PubMed ID: 12475743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats.
    Ogawa D; Shikata K; Matsuda M; Okada S; Usui H; Wada J; Taniguchi N; Makino H
    Nephrol Dial Transplant; 2002 Dec; 17(12):2117-21. PubMed ID: 12454221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors.
    Ostendorf T; Van Roeyen C; Westenfeld R; Gawlik A; Kitahara M; De Heer E; Kerjaschki D; Floege J; Ketteler M
    J Am Soc Nephrol; 2004 Sep; 15(9):2307-19. PubMed ID: 15339980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.